The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

被引:4
|
作者
Yang, Yuxian [1 ]
Li, Shuting [1 ]
Xu, Yuechao [1 ]
Ke, Jing [1 ]
Zhao, Dong [1 ]
机构
[1] Capital Med Univ, Beijing Luhe Hosp, Ctr Endocrine Metab & Immune Dis, Beijing, Peoples R China
关键词
nonalcoholic fatty liver disease; perirenal fat thickness; paranephric fat thickness; type 2 diabetes mellitus; VISCERAL FAT; FIBROSIS; PREVALENCE; OBESITY; STEATOHEPATITIS; SEVERITY; RISK; LIPOTOXICITY; INFLAMMATION; MANAGEMENT;
D O I
10.2147/DMSO.S350579
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Obesity is an important risk factor for nonalcoholic fatty liver disease (NAFLD). Perirenal fat and paranephric fat were seldom studied in NAFLD. We aimed to explore the relationship between perirenal fat thickness (PrFT) and paranephric fat thickness (PnFT) and NAFLD in patients with type 2 diabetes mellitus (T2DM). Patients and Methods: A total of 493 diabetic patients including 231 NAFLD patients were enrolled in our study from September 2019 to December 2020. Patients with NAFLD were categorized into three subgroups according to the severity and fibrosis risk of NAFLD. Anthropometric indices and clinical characteristics were collected from clinical records. PrFT and PnFT were measured via ultrasound. Multivariate logistic regression analysis was used to assess the association between PrFT, PnFT and presence, severity and advanced fibrosis risk of NAFLD. Results: Compared with non-NAFLD patients, those with NAFLD had significantly higher PrFT and PnFT. The PrFT and PnFT were independently associated with presence of NAFLD and the PrFT was independently associated with the advanced fibrosis risk of NAFLD after adjusting confounding factors. Conclusion: The PrFT was independently associated with the presence and advanced fibrosis risk of NAFLD in patients with T2DM.
引用
收藏
页码:1505 / 1515
页数:11
相关论文
共 50 条
  • [21] Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
    Fan, Yanbo
    Xiong, Wei
    Li, Jingjing
    Hu, Aimin
    He, Zhiwei
    Zhang, Jiawen
    Zhou, Guoyun
    Yin, Qiang
    PHARMACEUTICAL BIOLOGY, 2018, 56 (01) : 567 - 572
  • [22] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Xueyang Zhang
    Ran Bai
    Yong Jia
    Junwei Zong
    Yongbo Wang
    Yanan Dong
    International Journal of Diabetes in Developing Countries, 2020, 40 : 491 - 499
  • [23] Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
    Bril, Fernando
    Cusi, Kenneth
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (04) : 765 - +
  • [24] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
    Ismail, Mona H.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (06): : 485 - 492
  • [25] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Zhang, Xueyang
    Bai, Ran
    Jia, Yong
    Zong, Junwei
    Wang, Yongbo
    Dong, Yanan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (04) : 491 - 499
  • [26] High prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in type 2 diabetes mellitus
    Thiruppathi, Shankar
    Falck-Ytter, Yngve
    Dasarathy, Srinivasan
    Rogers, Nicholette
    McCullough, Arthur J.
    HEPATOLOGY, 2006, 44 (04) : 660A - 660A
  • [27] Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
    Mantovani, Alessandro
    Rigolon, Riccardo
    Pichiri, Isabella
    Bonapace, Stefano
    Morani, Giovanni
    Zoppini, Giacomo
    Bonora, Enzo
    Targher, Giovanni
    PLOS ONE, 2017, 12 (10):
  • [28] The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial
    Khaliq, Adil
    Badshah, Haroon
    Shah, Yasar
    Rehman, Inayat Ur
    Khan, Kashif Ullah
    Ming, Long Chiau
    Cheng, Maong Hui
    MEDICINE, 2024, 103 (45)
  • [29] Low serum levels of bone turnover markers are associated with perirenal fat thickness in patients with type 2 diabetes mellitus
    Jia, Xiaoxia
    An, Yaxin
    Xu, Yuechao
    Yang, Yuxian
    Liu, Chang
    Zhao, Dong
    Ke, Jing
    ENDOCRINE CONNECTIONS, 2021, 10 (10) : 1337 - 1343
  • [30] Hepatotoxicity Associated with Metformin Therapy in Treatment of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease
    Cone, Catherine J.
    Bachyrycz, Amy M.
    Murata, Glen H.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (10) : 1655 - 1659